These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
245 related items for PubMed ID: 12519833
1. A randomized controlled trial of estrogen replacement therapy in long-term users of depot medroxyprogesterone acetate. Cundy T, Ames R, Horne A, Clearwater J, Roberts H, Gamble G, Reid IR. J Clin Endocrinol Metab; 2003 Jan; 88(1):78-81. PubMed ID: 12519833 [Abstract] [Full Text] [Related]
2. Bone density in women receiving depot medroxyprogesterone acetate for contraception. Cundy T, Evans M, Roberts H, Wattie D, Ames R, Reid IR. BMJ; 1991 Jul 06; 303(6793):13-6. PubMed ID: 1830502 [Abstract] [Full Text] [Related]
3. Long-term depot-medroxyprogesterone acetate and bone mineral density. Tang OS, Tang G, Yip P, Li B, Fan S. Contraception; 1999 Jan 06; 59(1):25-9. PubMed ID: 10342083 [Abstract] [Full Text] [Related]
4. Depot medroxyprogesterone acetate, oral contraceptives and bone mineral density in a cohort of adolescent girls. Cromer BA, Stager M, Bonny A, Lazebnik R, Rome E, Ziegler J, Debanne SM. J Adolesc Health; 2004 Dec 06; 35(6):434-41. PubMed ID: 15581522 [Abstract] [Full Text] [Related]
5. Prevalence of Low Bone Mass and Osteoporosis in Long-Term Users of the Injectable Contraceptive Depot Medroxyprogesterone Acetate. Modesto W, Bahamondes MV, Bahamondes L. J Womens Health (Larchmt); 2015 Aug 06; 24(8):636-40. PubMed ID: 26098552 [Abstract] [Full Text] [Related]
6. Bone density among long-term users of medroxyprogesterone acetate as a contraceptive. Paiva LC, Pinto-Neto AM, Faundes A. Contraception; 1998 Dec 06; 58(6):351-5. PubMed ID: 10095971 [Abstract] [Full Text] [Related]
7. Bone density in long term users of depot medroxyprogesterone acetate. Gbolade B, Ellis S, Murby B, Randall S, Kirkman R. Br J Obstet Gynaecol; 1998 Jul 06; 105(7):790-4. PubMed ID: 9692421 [Abstract] [Full Text] [Related]
8. Bone mineral density at various anatomic bone sites in women receiving combined oral contraceptives and depot-medroxyprogesterone acetate for contraception. Wanichsetakul P, Kamudhamas A, Watanaruangkovit P, Siripakarn Y, Visutakul P. Contraception; 2002 Jun 06; 65(6):407-10. PubMed ID: 12127638 [Abstract] [Full Text] [Related]
9. Decline in bone mineral density with stress fractures in a woman on depot medroxyprogesterone acetate. A case report. Harkins GJ, Davis GD, Dettori J, Hibbert ML, Hoyt RA. J Reprod Med; 1999 Mar 06; 44(3):309-12. PubMed ID: 10202754 [Abstract] [Full Text] [Related]
10. Bone mineral density in adolescent females using injectable or oral contraceptives: a 24-month prospective study. Cromer BA, Bonny AE, Stager M, Lazebnik R, Rome E, Ziegler J, Camlin-Shingler K, Secic M. Fertil Steril; 2008 Dec 06; 90(6):2060-7. PubMed ID: 18222431 [Abstract] [Full Text] [Related]
11. [Status of bone mineral density after the long-standing application of contraception Depo-Provera]. Zeman S, Havlík P, Zemanová J, Němec D. Ceska Gynekol; 2013 Jan 06; 78(1):116-24. PubMed ID: 23607391 [Abstract] [Full Text] [Related]
12. A cross-sectional study of the forearm bone mineral density in long-term current users of the injectable contraceptive depot medroxyprogesterone acetate. Viola AS, Castro S, Bahamondes MV, Fernandes A, Viola CF, Bahamondes L. Contraception; 2011 Nov 06; 84(5):e31-7. PubMed ID: 22018135 [Abstract] [Full Text] [Related]
13. Bone mineral density changes over two years in first-time users of depot medroxyprogesterone acetate. Clark MK, Sowers MR, Nichols S, Levy B. Fertil Steril; 2004 Dec 06; 82(6):1580-6. PubMed ID: 15589863 [Abstract] [Full Text] [Related]
14. Effect of depot medroxyprogesterone acetate on bone mineral density in adolescent women. Zhang MH, Zhang W, Zhang AD, Yang Y, Gai L. Chin Med J (Engl); 2013 Nov 06; 126(21):4043-7. PubMed ID: 24229671 [Abstract] [Full Text] [Related]
15. Menopausal bone loss in long-term users of depot medroxyprogesterone acetate contraception. Cundy T, Cornish J, Roberts H, Reid IR. Am J Obstet Gynecol; 2002 May 06; 186(5):978-83. PubMed ID: 12015524 [Abstract] [Full Text] [Related]
16. Bone mineral density in long-term depot medroxyprogesterone acetate acceptors. Taneepanichskul S, Intaraprasert S, Theppisai U, Chaturachinda K. Contraception; 1997 Jul 06; 56(1):1-3. PubMed ID: 9306024 [Abstract] [Full Text] [Related]
17. Combination treatment with estrogen and calcitriol in the prevention of age-related bone loss. Gallagher JC, Fowler SE, Detter JR, Sherman SS. J Clin Endocrinol Metab; 2001 Aug 06; 86(8):3618-28. PubMed ID: 11502787 [Abstract] [Full Text] [Related]
18. The effect of past use of the injectable contraceptive depot medroxyprogesterone acetate on bone mineral density in normal post-menopausal women. Orr-Walker BJ, Evans MC, Ames RW, Clearwater JM, Cundy T, Reid IR. Clin Endocrinol (Oxf); 1998 Nov 06; 49(5):615-8. PubMed ID: 10197077 [Abstract] [Full Text] [Related]
19. Further evaluation on long-term depot-medroxyprogesterone acetate use and bone mineral density: a longitudinal cohort study. Tang OS, Tang G, Yip PS, Li B. Contraception; 2000 Oct 06; 62(4):161-4. PubMed ID: 11137068 [Abstract] [Full Text] [Related]
20. Bone Mineral Density and Weight Changes in Adolescents Randomized to 3 Doses of Depot Medroxyprogesterone Acetate. Lange HL, Manos BE, Gothard MD, Rogers LK, Bonny AE. J Pediatr Adolesc Gynecol; 2017 Apr 06; 30(2):169-175. PubMed ID: 27789350 [Abstract] [Full Text] [Related] Page: [Next] [New Search]